SYNCRIP and Mobius syndrome: Since SYNCRIP expression was elevated in Group 3 MB compared to the non-tumor group at a high level of significance in the Swartling dataset (p = 2.01 × 10−19), overall, our study shows that, in addition to being on the Northcott list of driver genes [16], SYNCRIP is significantly related to the survival of Group 3 MBs.